Biological E’s novel oral type 2 polio vax gets WHO ph II nod
Biological E’s novel oral type 2 polio vax gets WHO ph II nod is drawing significant interest across the industry.
Hyderabad: The World Health Organization (WHO) has granted Phase II pre-qualification (PQ) to Biological E's novel oral polio vaccine type 2 (nOPV2), .
Experts suggest this could influence future trends and innovation in the sector.
More updates are expected as the story develops.
Related Articles
- Monmouth boys basketball fends off Machias to win Class D title
- Plans approved to transform Kearnsey Abbey play area in Dover after £150k investment
- World War III: List of safest countries to seek shelter if WWIII breaks out amid Israel-Iran conflict
- Kahkwa Club will host 126th Western PGA Amateur Championship
Source: Original →